Email This Article

Subpoena May Spoil Genentech's Earnings Party
By Robert Steyer
10/06/04 - 04:13 PM EDT
The company has high hopes for two new drugs, but a probe into Rituxan may divert investors' attention.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,274.71 1,086.24 2,125.95 32.01
Oil *
75.15
DOWN
189.69
DOWN
24.39
DOWN
50.10
DOWN
0.78
10 Yr
3.20%
SPDR Gold
116.62
-1.81%
-2.20%
-2.30%
-2.38%
Data delayed 20 minutes

Brokerage Partners